Medicared For All Logo

Moustafa Eldick in Crescent City, Florida

Home Florida Crescent City

Moustafa Eldick has Internal Medicine as his primary medical specialty. Their primary office is: 899 N Summit St in Crescent City, Florida. There is an additional office location, for a total of two, for Moustafa Eldick that can be viewed further down. They attended Sorry, his university is not listed and graduated in 1986 (around 38 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Moustafa M Eldick Office Phone and Directions

Moustafa Eldick
899 N Summit St
Crescent City, Florida 32112
386-689-1088


Patient Ratings
Please rate your experience with Moustafa Eldick below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 386-689-1088


Enter a starting address:


Healthcare Info for Moustafa Eldick

Medical School: Sorry, his university is not listed
Graduation Year: 1986
The Primary Medical Specialty for Moustafa Eldick is listed as: Internal Medicine
Approximate Years of Experience: 38
PAC (PECOS ID)#: 7113074469
NPI #: 1962592907
NPI Created On: 10/13/2006
NPI Last Updated Listed as: 11/20/2007
Primary Taxonomy Code: 207R00000X
License Number:
ME0064833
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic.


Services and Procedures include:

  1. Injections of tendon sheath, ligament, or muscle membrane
  2. Insertion of needle into vein for collection of blood sample
  3. Vaccine for influenza for administration into muscle, 0.5 ml dosage
  4. Routine ekg using at least 12 leads including interpretation and report
  5. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  7. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
  8. Ultrasound study of arteries of both arms and legs
  9. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  10. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
  11. Testing of autonomic (sympathetic) nervous system function
  12. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  13. New patient office or other outpatient visit, typically 30 minutes
  14. New patient office or other outpatient visit, typically 45 minutes
  15. Established patient office or other outpatient visit, typically 5 minutes
  16. Established patient office or other outpatient visit, typically 15 minutes
  17. Established patient office or other outpatient, visit typically 25 minutes
  18. Initial hospital inpatient care, typically 70 minutes per day
  19. Subsequent hospital inpatient care, typically 25 minutes per day
  20. Hospital discharge day management, 30 minutes or less

They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401913

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: UBRELVY

Open Associated Drug #1: 0023-6501-10


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401923

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401925

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401929

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 794401931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: VRAYLAR

Open Associated Drug #1: 61874-115-31


Additional Office Locations

1.
126 S County Rd
Interlachen, FL 32148
Suite 315
Group Members: 0

Phone: 386-689-1088

Enter a starting address:


Internal Medicine Professionals in Crescent City

300 S Main St
Crescent-city, FL
Express Family Care

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry